相关实验视频
Updated: Jun 12, 2025

08:25
Identification of Circular RNAs using RNA Sequencing
Published on: November 14, 2019
12.2K
在人类骨质疏松症的管理中循环RNAs
Giuseppe Gargano1,2, Simona M Pagano3, Nicola Maffulli4,5,6
1Department of Trauma and Orthopaedic Surgery, Hospital San Francesco D'Assisi, Via Michele Clemente, Oliveto Citra, SA 84020, Italy.
British medical bulletin
|January 17, 2025
概括
循环RNAs (CircRNAs) 通过向代谢过程和识别药物点,显示出对骨质疏松症 (OP) 治疗的希望. 然而,从体外研究中预测体内疗效仍然具有挑战性.
科学领域:
- 分子生物学分子生物学
- 遗传学 遗传学是一种遗传学.
- 在RNA生物学,RNA生物学.
背景情况:
- 骨质疏松症 (OP) 是一种代谢性骨病,其特点是骨质减少和骨质脆弱性增加.
- 圆形核糖核酸 (CircRNAs) 是独特的RNA分子,具有潜在的治疗应用.
- 循环RNA可以作为分子标或用于新的治疗策略.
研究的目的:
- 系统地审查CircRNAs在骨质疏松症 (OP) 治疗中的作用.
- 使用CircRNAs识别OP的潜在治疗点和药物治疗方法.
- 探索CircRNAs在理解OP的代谢过程中的应用.
主要方法:
- 在2024年7月之前,对多个数据库进行了全面的系统搜索.
- 确定并分析了17项相关研究,调查了OP治疗中的CircRNA.
主要成果:
- 循环RNAs在阐明OP的代谢途径方面显示出潜在的实用性.
- 它们可以帮助确定治疗点和治疗骨质疏松症的新药疗法.
- 循环RNAs通过各种基因和细胞因子调节OP中的代谢过程.
结论:
- 循环RNAs可以影响受OP基因失调和生长因子影响的代谢过程.
- 在预测体外CircRNA反应和药物相互作用的体内适用性方面仍然存在重大挑战.
- 需要进行进一步的研究,以弥合OP的基于CircRNA的治疗方法在体外可预测性和体内疗效之间的差距.
相关概念视频
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Bone Remodeling
38.2K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.2K
The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
lncRNA - Long Non-coding RNAs
8.5K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.5K

